SMALL LYMPHOCYTIC LYMPHOMA
Clinical trials for SMALL LYMPHOCYTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new SMALL LYMPHOCYTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for SMALL LYMPHOCYTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental NK cell cocktail aims to outsmart resistant lymphoma
Disease control Not yet recruitingThis early-phase trial tests a combination of two antibody drugs (rituximab and tafasitamab) plus donated natural killer (NK) immune cells for people with B-cell non-Hodgkin lymphoma that has returned or not responded to at least two prior treatments. Up to 15 participants will r…
Matched conditions: SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE1 • Sponsor: Paolo Caimi, MD • Aim: Disease control
Last updated May 26, 2026 05:09 UTC
-
Leukemia patients may get a break from daily pills
Disease control Not yet recruitingThis study looks at whether people with chronic lymphocytic leukemia (CLL) who have been in remission for at least two years can safely stop taking their BTK inhibitor medication. Researchers will track how long patients stay cancer-free without treatment, and whether quality of …
Matched conditions: SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:34 UTC
-
New drug cocktail aims to outsmart tough blood cancers
Disease control Not yet recruitingThis study tests a new drug, NX-5948, combined with other medicines (venetoclax and possibly rituximab or obinutuzumab) in adults with B-cell cancers such as lymphoma, chronic lymphocytic leukemia, and small lymphocytic lymphoma. The goal is to see if the combination is safe and …
Matched conditions: SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Nurix Therapeutics, Inc. • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
New hope for Tough-to-Treat blood cancers: phase 3 trial launches
Disease control Not yet recruitingThis study tests a new drug, NX-5948, against another drug, pirtobrutinib, in people with chronic lymphocytic leukemia or small lymphocytic lymphoma that has returned or stopped responding to prior treatment. About 620 adults whose cancer progressed after a previous BTK inhibitor…
Matched conditions: SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE3 • Sponsor: Nurix Therapeutics, Inc. • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
New drug duo aims to wipe out hidden leukemia cells
Disease control Not yet recruitingThis study tests two oral drugs, nemtabrutinib and venetoclax, given together as the first treatment for people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The goal is to see if the combination can clear even the tiniest traces of cancer from the …
Matched conditions: SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE2 • Sponsor: Jennifer Woyach • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New drug cocktail aims to deeply suppress blood cancer
Disease control Not yet recruitingThis study tests a combination of three drugs (acalabrutinib, venetoclax, and tafasitamab) in 35 adults with previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma. The goal is to see if the combo is safe and can achieve a complete response with undetecta…
Matched conditions: SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 13, 2026 16:02 UTC